News Archives - Page 18 of 87

FridayJan 19, 2024 12:51 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Names Seasoned Biotech Leader to Board of Directors

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has appointed a biotech veteran to its board of directors. The company announced that Amy Mahery, a highly accomplished biopharmaceutical industry executive, will join the company’s board effective upon completion of financing. With more than 20 years of experience working with large and small companies in common and rare conditions, Mahery brings impressive expertise in the commercialization and launch of drugs in varied therapeutic areas, including oncology, neurology, and immunology, to her new responsibilities.…

ThursdayJan 18, 2024 1:35 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Sporty Five RS Featured in Recent CarScoops Article

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, and its just-announced Five RS is being spotlighted by CarScoops. Mullen unveiled the high-performance version of its crossover at the Consumer Electronics Show (“CES”) in Las Vegas, and CarScoops notes that the model has an intriguing design, big performance claims and a production date set for late 2025. The article pointed out key features of Mullen’s latest offering, including its fast-charging capabilities, integrated infotainment system, artificial intelligence (“AI”)-based personal assistance called Persona, facial recognition technology and level 2+ driver assistance tech. “Although seeing EVs with impressive performance figures is nothing…

ThursdayJan 18, 2024 1:00 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reaches Planned Enrollment Berubicin Study for the Treatment of GBM

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has completed enrollment in its global potentially pivotal study evaluating Berubicin. According to the announcement, the study has enrolled 247 patients across 46 clinical trial sites in the United States, Italy, France, Spain and Switzerland. A novel anthracycline, Berubicin appears to be the first anthracycline to cross the blood-brain barrier for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. The Berubicin study is a multicenter, open-label, randomized controlled study…

WednesdayJan 17, 2024 4:53 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Partners with Kawasaki in Contract for Cross-Border Logistics Services

Freight Technologies (NASDAQ: FRGT), a technology company specializing in the development of innovative solutions to optimize and automate the supply chain process through its custom-developed F8App platform, has entered into a contract with Kawasaki Motores de Mexico for cross-border logistics services. According to the announcement, Fr8App is already orchestrating the cross-border logistics for Kawasaki’s popular Jet Ski models, which has provided an opportunity to demonstrate the platform’s adaptability and efficiency in handling diverse transportation requirements. In a selection that goes beyond simple technology adoption, Kawasaki Motores de Mexico officials noted that Fr8App was chosen because the company aligns seamlessly with…

WednesdayJan 17, 2024 4:34 pm

TinyGemsBreaks – Diamond Lake Minerals Inc. (DLMI) CEO Talks 2024 Outlook in Recent Proactive Interview

Diamond Lake Minerals (OTC: DLMI), a leading player in the digital asset landscape bridging the gap between traditional finance and decentralized finance, is featured in a recent interview released from Proactive. During the interview, Diamond Lake Minerals CEO Brian J. Esposito talked with Proactive host Steve Darling about the company’s plans for 2024. During the discussion, Esposito explained that Diamond Lake Minerals employs an innovative approach, operating as a parent umbrella conglomerate with multiple subsidiaries spanning various industries. Esposito noted that the company goal is to emulate the structure of General Electric, which is recognized for its diversified portfolio across industries. Esposito…

WednesdayJan 17, 2024 2:04 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on 2023 Financial Results, Provides Business Update

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released a report on its financial results for the 12-month period ended Sept. 30, 2023; the company also reported on its current business operations. In the report, the company noted key achievements throughout the year, including the company recording its first revenues of $366,000 and delivering vehicles valued at $652,200 to Randy Marion Automotive for resale in September; the production of Class 3 (the Mullen THREE) vehicles beginning in August 2023 and production Class 1 (the Mullen ONE) beginning in November 2023; and by year-end delivering 100 Class 1…

WednesdayJan 17, 2024 9:51 am

TinyGemsBreaks – GEMXX Corporation (GEMZ) Announces Participation at Sequire Investor Summit in Puerto Rico

GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment, will be presenting at this month’s Sequire Investor Summit 2024. Sequire Investor Summit: Puerto Rico is slated for Jan. 23–25, 2024, in San Juan. According to the announcement, the three-day event is designed to provide an array of exciting opportunities for funds, companies and investors. The event agenda features more than 40 presentations from leading public companies as well as panel discussions and interactive sessions focused on addressing the latest trends and innovations in investor relations and technology. Puerto Rico was chosen as the site because it is home…

TuesdayJan 16, 2024 3:45 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) ‘Ready to Challenge’ with New Five RS SUV, Reports ‘Road Track’ Article

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, and its Mullen Five RS were spotlighted in a recent “Road Track” article. The article noted that the sporty new model, which was revealed at CES 2024, is “ready to challenge Tesla and Lucid in the performance EV space. . . . Known as the Mullen Five RS, this electric crossover promises to bring over 1000 hp and a sub-2.0-second 0-60 mph sprint.” The article provided a background look at Mullen, which was incorporated in 2014 and comprises pieces of Coda Motor Cars and Mullen Motors. Calling the Five RS…

TuesdayJan 16, 2024 3:13 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Extensive GLP-1 Study Program

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today unveiled a comprehensive planned applied research program to thoroughly evaluate DehydraTECH for the improved delivery of GLP-1 drugs, designed to support prospective commercial partnering with global pharmaceutical companies. In a recent human pilot study with seven volunteers, Lexaria demonstrated superior pharmacokinetic (“PK”) oral delivery performance of the DehydraTECH-enhanced glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially in the branded product Rybelsus(R). The positive results were sufficient to encourage a much more thorough and expanded investigation. The objective of the new planned studies, as detailed in the announcement, is…

TuesdayJan 16, 2024 2:26 pm

TinyGemsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message

Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, has released a message for its shareholders from CEO Mark Dybul. In the message, Dybul provides an update about key developments the company experienced during 2023, including signing a definitive agreement to combine with the European-based, cutting-edge artificial-intelligence (“AI”) company GEDi Cube; GEDi Cube’s partnership with NVIDIA to expand its multiomic capabilities to multimodal; and consistently achieving “the holy grail of cancer research” in preclinical studies. The company has also scheduled a shareholder meeting on Jan. 25, 2024, to vote…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: News